In terms of de novo T-cell priming, CDCs and TLR-P DCs as well as the LPS/IFNγ DCs, which served as a positive control, were able to induce tumor-antigen-specific CD8+ T-cells at similar frequencies with a trend for higher proliferation of T-cells in the TLR-P group. This evidence concerns the gene CD8A and neoplasm.